560 related articles for article (PubMed ID: 16618472)
1. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey.
Torrance N; Smith BH; Bennett MI; Lee AJ
J Pain; 2006 Apr; 7(4):281-9. PubMed ID: 16618472
[TBL] [Abstract][Full Text] [Related]
2. Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin.
Torrance N; Smith BH; Watson MC; Bennett MI
Fam Pract; 2007 Oct; 24(5):481-5. PubMed ID: 17670804
[TBL] [Abstract][Full Text] [Related]
3. Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community.
Smith BH; Torrance N; Bennett MI; Lee AJ
Clin J Pain; 2007 Feb; 23(2):143-9. PubMed ID: 17237663
[TBL] [Abstract][Full Text] [Related]
4. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research.
Bennett MI; Smith BH; Torrance N; Potter J
J Pain; 2005 Mar; 6(3):149-58. PubMed ID: 15772908
[TBL] [Abstract][Full Text] [Related]
5. The impact of chronic pain in the community.
Smith BH; Elliott AM; Chambers WA; Smith WC; Hannaford PC; Penny K
Fam Pract; 2001 Jun; 18(3):292-9. PubMed ID: 11356737
[TBL] [Abstract][Full Text] [Related]
6. Identifying neuropathic pain among patients with chronic low-back pain: use of the Leeds Assessment of Neuropathic Symptoms and Signs pain scale.
Kaki AM; El-Yaski AZ; Youseif E
Reg Anesth Pain Med; 2005; 30(5):422-8. PubMed ID: 16135345
[TBL] [Abstract][Full Text] [Related]
7. Can chronic neuropathic pain following thoracic surgery be predicted during the postoperative period?
Searle RD; Simpson MP; Simpson KH; Milton R; Bennett MI
Interact Cardiovasc Thorac Surg; 2009 Dec; 9(6):999-1002. PubMed ID: 19767301
[TBL] [Abstract][Full Text] [Related]
8. Validity and reliability of the Turkish Self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire.
Koc R; Erdemoglu AK
Pain Med; 2010 Jul; 11(7):1107-14. PubMed ID: 20456071
[TBL] [Abstract][Full Text] [Related]
9. Translation and linguistic validation of the self-completed Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) scale for use in a Libyan population.
Elzahaf RA; Tashani OA; Unsworth BA; Johnson MI
Pain Pract; 2013 Mar; 13(3):198-205. PubMed ID: 22726274
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Nepali Version of the Self-reported Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) in Adults With Chronic Pain and Predominantly Low-literacy Levels.
Sharma S; Higgins C; Cameron P; Bimali I; Hales TG; Bennett MI; Colvin L; Smith BH
J Pain; 2022 Mar; 23(3):424-433. PubMed ID: 34583020
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of neuropathic pain among patients with chronic low-back pain in the Arabian Gulf Region assessed using the leeds assessment of neuropathic symptoms and signs pain scale.
El Sissi W; Arnaout A; Chaarani MW; Fouad M; El Assuity W; Zalzala M; Dershaby YE; Youseif E
J Int Med Res; 2010; 38(6):2135-45. PubMed ID: 21227019
[TBL] [Abstract][Full Text] [Related]
12. Validation of the S-LANSS in the community setting.
Weingarten TN; Watson JC; Hooten WM; Wollan PC; Melton LJ; Locketz AJ; Wong GY; Yawn BP
Pain; 2007 Nov; 132(1-2):189-94. PubMed ID: 17869424
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of chronic pain with neuropathic characteristics in the Moroccan general population: a national survey.
Harifi G; Amine M; Ait Ouazar M; Boujemaoui A; Ouilki I; Rekkab I; Belkhou A; El Bouchti I; Niamane R; El Hassani S
Pain Med; 2013 Feb; 14(2):287-92. PubMed ID: 23241023
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of two questionnaires for the detection of neuropathic pain in the Spanish population.
Hamdan A; Luna JD; Del Pozo E; Gálvez R
Eur J Pain; 2014 Jan; 18(1):101-9. PubMed ID: 23776139
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) questionnaire and its correlation with visual analog pain scales in Greek population.
Spanos K; Lachanas VA; Chan P; Bargiota A; Giannoukas AD
J Diabetes Complications; 2015; 29(8):1142-5. PubMed ID: 26345340
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of chronic pain with neuropathic characteristics in the general population.
Bouhassira D; Lantéri-Minet M; Attal N; Laurent B; Touboul C
Pain; 2008 Jun; 136(3):380-387. PubMed ID: 17888574
[TBL] [Abstract][Full Text] [Related]
17. An Epidemiological Study of Neuropathic Pain Symptoms in Canadian Adults.
VanDenKerkhof EG; Mann EG; Torrance N; Smith BH; Johnson A; Gilron I
Pain Res Manag; 2016; 2016():9815750. PubMed ID: 27445636
[TBL] [Abstract][Full Text] [Related]
18. Neuropathic pain in the community: more under-treated than refractory?
Torrance N; Ferguson JA; Afolabi E; Bennett MI; Serpell MG; Dunn KM; Smith BH
Pain; 2013 May; 154(5):690-699. PubMed ID: 23485369
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity and Specificity of a Neuropathic Screening Tool (Self-Report Leeds Assessment of Neuropathic Symptoms and Signs, S-LANSS) in Adolescents With Moderate-Severe Chronic Pain.
Walker SM; Peters J; Verriotis M; Farag F; Jay MA; Howard RF
J Pain; 2024 Feb; 25(2):451-465. PubMed ID: 37741521
[TBL] [Abstract][Full Text] [Related]
20. Use of S-LANSS, a tool for screening neuropathic pain, for predicting postherpetic neuralgia in patients after acute herpes zoster events: a single-center, 12-month, prospective cohort study.
Cho SI; Lee CH; Park GH; Park CW; Kim HO
J Pain; 2014 Feb; 15(2):149-56. PubMed ID: 24342706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
